Tranexamic acid to prevent heavy bleeding after C-section in autoimmune disease
Treatments studied
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a planned or emergency C-section.
- You have an autoimmune disease like lupus, antiphospholipid syndrome, scleroderma, Sjogren's syndrome, rheumatoid arthritis, or undifferentiated connective tissue disease.
- You are not allergic to tranexamic acid.
- You do not have a history of blood clots or bleeding problems.
- Your kidneys are working well (no severe kidney failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This study looks at how tranexamic acid, a medicine to reduce bleeding, is given to people who have heavy bleeding after a cesarean delivery. It may help doctors improve treatment for this condition.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial is for women having their second or third planned c-section. It tests if giving a medicine called tranexamic acid helps prevent heavy bleeding. The medicine is safe and commonly used to reduce bleeding.
This trial tests whether giving a medicine called tranexamic acid before a planned C-section can help prevent dangerous heavy bleeding after birth. It is for pregnant women with low-risk pregnancies who are scheduled for a planned C-section.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.